The Filing Desk

CG Oncology vs Prime Medicine

CG Oncology CGON · Prime Medicine PRME · Biotechnology

Prime Medicine reported revenue of $5 million in fiscal 2025, 1.1 times CG Oncology's $4 million in fiscal 2025. CG Oncology's revenue grew 254.7% in its latest year, and Prime Medicine's grew 55.3%. CG Oncology had an operating margin of -4722.1%, against -4498.1% at Prime Medicine. Free cash flow was −$132 million at CG Oncology and −$167 million at Prime Medicine.

Side by side

CG OncologyPrime Medicine
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$4M$5M
Revenue growth254.7%55.3%
Revenue growth a year, last 5 years—−2.4%
Gross margin——
Operating margin−4,722.1%−4,498.1%
Net margin−3,985.0%−4,342.4%
Free cash flow−$132M−$167M
Free cash flow margin−3,279.2%−3,607.4%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count23.7%25.4%
Last close$74.40$4.27
P/E at the last close——
Insider trades, last 12 monthsbought $24.8 million, sold $4.8 million—
Piotroski F-score2 of 8—
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
CG OncologyPrime Medicine
Operating margin
Percent of revenue
CG OncologyPrime Medicine
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
CG OncologyPrime Medicine

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the CG Oncology and Prime Medicine pages.